To demonstrate that LLC-tumor bearing mice cured on RT+L19–IL2+anti-PD-L1 treatment developed a protective immune memory effect, we assessed the presence of central and CD127+ memory CD8+ T cells in the spleen and bone marrow of these mice. Here, IL2 is linked to neoplasm.